Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials

[1] Chen H(2020)KRAS oncogene may be another target conquered in non-small cell lung cancer (NSCLC) Thorac Cancer. 11 3425-3435

[2] Zhao J(2001)Fatal adverse drug events: the paradox of drug treatment J Intern Med. 250 327-341

[3] Buajordet I(2018)Prevalence of drug–drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials BMC Cancer. 18 1155-326

[4] Ebbesen J(2020)An overview of prevalence, determinants and health outcomes of polypharmacy TherAdv Drug Saf. 11 2042098620933741-4744

[5] Erikssen J(1989)Drug-induced illness as a cause for admission to a community hospital J Am Geriatr Soc. 37 323-1114

[6] Brors O(2009)Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients Anticancer Res. 29 4741-600

[7] Hilberg T(2007)Drug combinations with the potential to interact among cancer patients Support Care Cancer. 15 1113-1078

[8] Marcath LA(2007)Potential drug interactions and duplicate prescriptions among cancer patients J Natl Cancer Inst. 99 592-2341

[9] Coe TD(2013)Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs Br J Cancer. 108 1071-e326

[10] Hoylman EK(2011)Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method Ann Oncol. 22 2334-655

[1] Chen H(2020)KRAS oncogene may be another target conquered in non-small cell lung cancer (NSCLC) Thorac Cancer. 11 3425-3435

[2] Zhao J(2001)Fatal adverse drug events: the paradox of drug treatment J Intern Med. 250 327-341

[3] Buajordet I(2018)Prevalence of drug–drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials BMC Cancer. 18 1155-326

[4] Ebbesen J(2020)An overview of prevalence, determinants and health outcomes of polypharmacy TherAdv Drug Saf. 11 2042098620933741-4744

[5] Erikssen J(1989)Drug-induced illness as a cause for admission to a community hospital J Am Geriatr Soc. 37 323-1114

[6] Brors O(2009)Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients Anticancer Res. 29 4741-600

[7] Hilberg T(2007)Drug combinations with the potential to interact among cancer patients Support Care Cancer. 15 1113-1078

[8] Marcath LA(2007)Potential drug interactions and duplicate prescriptions among cancer patients J Natl Cancer Inst. 99 592-2341

[9] Coe TD(2013)Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs Br J Cancer. 108 1071-e326

[10] Hoylman EK(2011)Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method Ann Oncol. 22 2334-655